Page last updated: 2024-08-25

methotrexate and Hormone-Dependent Neoplasms

methotrexate has been researched along with Hormone-Dependent Neoplasms in 43 studies

Research

Studies (43)

Timeframe	Studies, this research(%)	All Research%
pre-1990	10 (23.26)	18.7374
1990's	9 (20.93)	18.2507
2000's	20 (46.51)	29.6817
2010's	4 (9.30)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barba, M; Del Medico, P; Di Lauro, L; Giannarelli, D; Laudadio, L; Maugeri-Saccà, M; Pizzuti, L; Sergi, D; Tomao, S; Vici, P	1
Abdel-Fatah, TM; Ball, GR; Chan, SY; Ellis, IO; Johnson, C; McArdle, SE; Moseley, PM; Pockley, AG; Rees, RC	1
Castiglione-Gertsch, M; Coates, AS; Collins, J; Crivellari, D; Fey, MF; Forbes, JF; Gelber, RD; Gelber, S; Goldhirsch, A; Holmberg, SB; Lindtner, J; Murray, E; Pagani, O; Price, KN; Simoncini, E; Thürlimann, B	1
Beraki, E; Kåresen, R; Naume, B; Park, D; Sauer, T; Synnestvedt, M	1
Bedognetti, D; Boccardo, F; Bruzzi, P; Del Mastro, L; Gardin, G; Monzeglio, C; Pastorino, S; Pronzato, P; Queirolo, P; Sertoli, MR; Siffredi, G; Taveggia, P; Venturini, M; Wang, E; Zanardi, E	1
Boussen, H; Gebbia, V; Valerio, MR	1
Albanell, J; Aranda, J; Campbell, J; Camps, C; Candel, MT; Carrato, A; Casado, A; Diaz-Rubio, E; Gonzalez, R; Lizon, J; Martin, M; Massuti, B; Munarriz, B; Sole-Calvo, A; Villar, A	1
Licun, W; Tannock, IF	1
Dietze, O; Filipits, M; Grill, R; Hausmaninger, H; Jakesz, R; Kubista, E; Lax, S; Pirker, R; Pohl, G; Rudas, M; Samonigg, H; Zielinski, CC	1
Andersson, J; Bergh, J; Carlsson, G; Gustavsson, B; Holmberg, L; Inganäs, M; Klaar, S; Larsson, L; Nilsson, J; Ohd, J; Rudenstam, CM	1
Castiglione-Gertsch, M; Coates, AS; Colleoni, M; Collins, J; Crivellari, D; Erzen, D; Forbes, J; Gelber, RD; Goldhirsch, A; Holmberg, S; Li, S; Lindtner, J; Murray, E; Pagani, O; Price, KN; Rudenstam, CM; Simoncini, E; Thürlimann, B; Veronesi, A	1
Bae, JY; Bae, YJ; Han, MR; Han, W; Hwang, KT; Hwang, SE; Kang, JJ; Kim, SW; Lee, JE; Lee, JH; Noh, DY; Shin, HJ	1
Bengtsson, NO; Bergh, J; Cold, S; de Graaf, PW; Edlund, P; Ejlertsen, B; Ewertz, M; Jensen, MB; Kamby, C; Mouridsen, HT; Nielsen, DL	1
Bafaloukos, D; Briasoulis, E; Dafni, U; Dimitrakakis, K; Dimopoulos, AM; Fountzilas, G; Gogas, H; Kalofonos, HP; Karanikiotis, C; Karina, M; Linardou, H; Makrantonakis, P; Markopoulos, C; Papadimitriou, C; Papakostas, P; Pectasides, D; Pisanidis, N; Polichronis, A; Samantas, E; Skarlos, D; Stathopoulos, GP; Tzorakoeleftherakis, E; Varthalitis, I; Xiros, N	1
Berdel, WE; Diallo-Danebrock, R; Frick, M; Gluz, O; Harbeck, N; Herr, A; Jackisch, C; Kates, R; Kirchner, H; Lindemann, W; Metzner, B; Mohrmann, S; Nitz, UA; Poremba, C; Schütt, G; Ting, E; Werner, F	1
Akashi-Tanaka, S; Ando, M; Fujiwara, Y; Hojo, T; Katsumata, N; Kinoshita, T; Kohno, T; Seki, K; Shibata, T; Shien, T; Shimizu, C	1
Braye, S; Brown, RW; Castiglione-Gertsch, M; Coates, AS; Gelber, RD; Goldhirsch, A; Golouh, R; Grigolato, P; Gusterson, BA; Kovács, A; Maiorano, E; Mastropasqua, MG; Ohlschlegel, C; Perin, T; Pillay, K; Price, KN; Regan, MM; Rusca, T; Viale, G	1
Manni, A; Pearson, OH; Trujillo, JE	1
Botte, G; Lo Russo, V; Oriana, S; Perozziello, F; Preda, F	1
Bonadonna, G; Valagussa, P	1
Brodovsky, H; Catalano, RB; Creech, RH; Glick, JH; Holroyde, C; Torri, S; Varano, M	1
Drago, JR; Goldman, LB	1
Drago, JR; Gershwin, ME; Goldman, LB	1
Coombes, RC; Corbishley, C; Ford, HT; Gazet, JC; Griffin, M; Lowndes, S; Makinde, V; Quilliam, J; Sutcliffe, R	1
Alken, P; Köhrmann, KU; Kreukler, C; Nebe, T; Siegsmund, MJ; Steidler, A	1
Malmström, P; Sjövall, MP	1
Denis, L	1
Aldrighetti, D; Amoroso, D; Boccardo, F; Bolognesi, A; Distante, V; Farris, A; Genta, F; Giai, M; Mesiti, M; Pacini, P; Romeo, D; Rubagotti, A; Sismondi, P	1
Branković-Magić, MV; Mitrovic, LB; Nesković-Konstantinović, ZB; Nikolić-Vukosavljević, DB; Spuzić, I	1
Dillon, JJ; Fleming, GF; Hartman, AR	1
Buyse, M; Di Leo, A	1
Avigan, D; Elias, AD; Frei, E; Ibrahim, J; Joyce, R; McCauley, M; Reich, E; Richardson, P; Wheeler, C	1
Cianfrocca, M; Goldstein, LJ	1
Goldfinger, N; Lilling, G; Nordenberg, J; Peller, S; Rotter, V; Sidi, Y	1
Harmon, JM; Norman, MR; Thompson, EB	1
Hellman, S; Little, JB; Nove, J; Piro, AJ; Weichselbaum, RR	1
Hochuli, E; Rageth, JC; Unger, C; Wyss, P	1
Ansari, R; Drasga, R; Einhorn, L; McClean, J; Miller, M; Saxman, S; Wheeler, B	1
Bartkowiak, J; Gaczyński, M; Kiliańska, Z; Krajewska, WM; Kłyszejko-Stefanowicz, L; Lipińska, A	1
Boulay, V; Brünner, N; Clarke, R; Leonessa, F; Thompson, EW; Wright, A	1
Fuchs, U; Merkle, E; Sauerbrei, W; Seidl, C; Wirtz, PM	1
Blaschke, U; Gerber, B; Kasch, R	1
Ivanova, OA; Moiseenko, VM; Semiglazov, VF	1

Reviews

5 review(s) available for methotrexate and Hormone-Dependent Neoplasms

Article	Year
Doxorubicin in combination with fluorouracil and cyclophosphamide (i.v. FAC regimen, day 1, 21) versus methotrexate in combination with fluorouracil and cyclophosphamide (i.v. CMF regimen, day 1, 21) as adjuvant chemotherapy for operable breast cancer: a Annals of oncology : official journal of the European Society for Medical Oncology, 2003, Volume: 14, Issue:6 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Female; Fluorouracil; Humans; Infusions, Intravenous; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasm Staging; Neoplasms, Hormone-Dependent; Prospective Studies; Survival Rate; Treatment Outcome	2003
Chemotherapy of breast cancer: current views and results. International journal of radiation oncology, biology, physics, 1983, Volume: 9, Issue:3 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Melphalan; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Prognosis; Receptors, Estrogen; Research Design	1983
Meta-analysis of adjuvant cyclophosphamide/methotrexate/5-fluorouracil chemotherapy in postmenopausal women with estrogen receptor-positive, node-positive breast cancer. Clinical breast cancer, 2001, Volume: 2, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Hormone-Dependent; Postmenopause; Receptors, Estrogen; Receptors, Progesterone; Survival Rate	2001
Operable breast cancer. Current treatment options in oncology, 2001, Volume: 2, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Doxorubicin; Female; Fluorouracil; Humans; Methotrexate; Neoadjuvant Therapy; Neoplasms, Hormone-Dependent; Practice Guidelines as Topic; Survival Analysis; Tamoxifen	2001
The biology of breast tumor progression. Acquisition of hormone independence and resistance to cytotoxic drugs. Acta oncologica (Stockholm, Sweden), 1992, Volume: 31, Issue:2 Topics: Animals; Breast Neoplasms; Colchicine; Drug Resistance; Female; Gene Expression Regulation, Neoplastic; Humans; Methotrexate; Mice; Mice, Nude; Models, Biological; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Phenotype; Tumor Cells, Cultured	1992

Trials

16 trial(s) available for methotrexate and Hormone-Dependent Neoplasms

Article	Year
Is adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12-93. Breast cancer research and treatment, 2009, Volume: 116, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Endocrine System; Female; Fluorouracil; Humans; International Agencies; Lymph Nodes; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasms, Hormone-Dependent; Postmenopause; Prognosis; Receptors, Estrogen; Survival Rate; Tamoxifen; Treatment Outcome	2009
Concurrent vs sequential adjuvant chemotherapy and hormone therapy in breast cancer: a multicenter randomized phase III trial. Journal of the National Cancer Institute, 2011, Oct-19, Volume: 103, Issue:20 Topics: Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Chemotherapy, Adjuvant; Confounding Factors, Epidemiologic; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Glucuronates; Humans; Italy; Kaplan-Meier Estimate; Lymph Node Excision; Mastectomy, Segmental; Methotrexate; Middle Aged; Multivariate Analysis; Neoplasm Staging; Neoplasms, Hormone-Dependent; Prognosis; Proportional Hazards Models; Receptors, Estrogen; Receptors, Progesterone; Risk Factors; Tamoxifen; Treatment Outcome	2011
Doxorubicin in combination with fluorouracil and cyclophosphamide (i.v. FAC regimen, day 1, 21) versus methotrexate in combination with fluorouracil and cyclophosphamide (i.v. CMF regimen, day 1, 21) as adjuvant chemotherapy for operable breast cancer: a Annals of oncology : official journal of the European Society for Medical Oncology, 2003, Volume: 14, Issue:6 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Female; Fluorouracil; Humans; Infusions, Intravenous; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasm Staging; Neoplasms, Hormone-Dependent; Prospective Studies; Survival Rate; Treatment Outcome	2003
Timing of CMF chemotherapy in combination with tamoxifen in postmenopausal women with breast cancer: role of endocrine responsiveness of the tumor. Annals of oncology : official journal of the European Society for Medical Oncology, 2005, Volume: 16, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Confidence Intervals; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluorouracil; Humans; Mastectomy, Segmental; Methotrexate; Middle Aged; Neoplasms, Hormone-Dependent; Postmenopause; Probability; Prognosis; Reference Values; Risk Assessment; Survival Rate; Tamoxifen; Time Factors; Treatment Outcome	2005
Similar efficacy for ovarian ablation compared with cyclophosphamide, methotrexate, and fluorouracil: from a randomized comparison of premenopausal patients with node-positive, hormone receptor-positive breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006, Nov-01, Volume: 24, Issue:31 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Female; Fluorouracil; Follow-Up Studies; Humans; Methotrexate; Middle Aged; Neoplasms, Hormone-Dependent; Odds Ratio; Ovary; Premenopause; Radiotherapy, Adjuvant; Survival Analysis	2006
Postoperative dose-dense sequential chemotherapy with epirubicin, paclitaxel and CMF in patients with high-risk breast cancer: safety analysis of the Hellenic Cooperative Oncology Group randomized phase III trial HE 10/00. Annals of oncology : official journal of the European Society for Medical Oncology, 2008, Volume: 19, Issue:5 Topics: Adult; Aged; Androstadienes; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Epirubicin; Estrogens; Female; Fluorouracil; Granulocyte Colony-Stimulating Factor; Hematologic Diseases; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Neoplasms, Hormone-Dependent; Neoplasms, Second Primary; Paclitaxel; Peripheral Nervous System Diseases; Tamoxifen	2008
Triple-negative high-risk breast cancer derives particular benefit from dose intensification of adjuvant chemotherapy: results of WSG AM-01 trial. Annals of oncology : official journal of the European Society for Medical Oncology, 2008, Volume: 19, Issue:5 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Carcinoma; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Epirubicin; Estrogens; Female; Fluorouracil; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Kaplan-Meier Estimate; Methotrexate; Middle Aged; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Proportional Hazards Models; Retrospective Studies; Single-Blind Method; Survival Analysis; Tamoxifen; Treatment Outcome	2008
Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Mar-20, Volume: 26, Issue:9 Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Female; Fluorouracil; Goserelin; Humans; Immunohistochemistry; Menopause; Methotrexate; Middle Aged; Neoplasms, Hormone-Dependent; Predictive Value of Tests; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Treatment Outcome	2008
Chemotherapy of breast cancer: current views and results. International journal of radiation oncology, biology, physics, 1983, Volume: 9, Issue:3 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Melphalan; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Prognosis; Receptors, Estrogen; Research Design	1983
Tamoxifen plus sequential CMF chemotherapy versus tamoxifen alone in postmenopausal patients with advanced breast cancer: a randomized trial. Cancer, 1980, Feb-15, Volume: 45, Issue:4 Topics: Antineoplastic Agents; Bone Marrow; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Menopause; Methotrexate; Middle Aged; Neoplasms, Hormone-Dependent; Receptors, Estrogen; Remission, Spontaneous; Tamoxifen	1980
European Organization for Research and Treatment of Cancer (EORTC) prostate cancer trials, 1976-1996. Urology, 1998, Volume: 51, Issue:5A Suppl Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Castration; Cyproterone Acetate; Diethylstilbestrol; Doxorubicin; Epirubicin; Estramustine; Flutamide; Humans; Imidazoles; Male; Medroxyprogesterone Acetate; Methotrexate; Mitomycin; Neoplasms, Hormone-Dependent; Procarbazine; Prostatic Neoplasms; Vindesine	1998
Cyclophosphamide, methotrexate, and fluorouracil versus tamoxifen plus ovarian suppression as adjuvant treatment of estrogen receptor-positive pre-/perimenopausal breast cancer patients: results of the Italian Breast Cancer Adjuvant Study Group 02 randomi Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:14 Topics: Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Goserelin; Humans; Methotrexate; Middle Aged; Neoplasms, Hormone-Dependent; Ovariectomy; Premenopause; Receptors, Estrogen; Survival Analysis; Tamoxifen	2000
Content of epidermal growth factor receptor in metastatic breast cancer: its role in endocrine sensitivity prediction. Neoplasma, 2000, Volume: 47, Issue:2 Topics: Adult; Aminoglutethimide; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; ErbB Receptors; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Ovariectomy; Predictive Value of Tests; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Survival Analysis; Tamoxifen; Treatment Outcome	2000
The impact of induction duration and the number of high-dose cycles on the long-term survival of women with metastatic breast cancer treated with high-dose chemotherapy with stem cell rescue: an analysis of sequential phase I/II trials from the Dana-Farbe Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2002, Volume: 8, Issue:4 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Carcinoma; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Estrogens; Female; Fluorouracil; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Life Tables; Melphalan; Methotrexate; Middle Aged; Multivariate Analysis; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Paclitaxel; Peripheral Blood Stem Cell Transplantation; Progesterone; Prognosis; Proportional Hazards Models; Remission Induction; Survival Analysis; Thiotepa; Time Factors; Treatment Outcome	2002
Phase III trial of cyclophosphamide versus cyclophosphamide, doxorubicin, and methotrexate in hormone-refractory prostatic cancer. A Hoosier Oncology Group study. Cancer, 1992, Nov-15, Volume: 70, Issue:10 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Male; Methotrexate; Middle Aged; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Remission Induction; Survival Analysis	1992
[Prospective randomized study of the efficacy of adjuvant hormone therapy in patients with breast cancer]. Voprosy onkologii, 1986, Volume: 32, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Diethylstilbestrol; Female; Fluorouracil; Humans; Levodopa; Menopause; Methotrexate; Middle Aged; Neoplasms, Hormone-Dependent; Prospective Studies; Random Allocation; Tamoxifen	1986

Other Studies

24 other study(ies) available for methotrexate and Hormone-Dependent Neoplasms

Article	Year
Letrozole combined with gonadotropin-releasing hormone analog for metastatic male breast cancer. Breast cancer research and treatment, 2013, Volume: 141, Issue:1 Topics: Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms, Male; Carcinoma, Ductal, Breast; Carcinoma, Papillary; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Docetaxel; Epirubicin; Estrogen Receptor Modulators; Estrogens; Fluorouracil; Gonadotropin-Releasing Hormone; Goserelin; Humans; Kaplan-Meier Estimate; Letrozole; Male; Mastectomy, Modified Radical; Methotrexate; Middle Aged; Neoplasms, Hormone-Dependent; Nitriles; Progesterone; Radiotherapy, Adjuvant; Tamoxifen; Taxoids; Triazoles	2013
HAGE (DDX43) is a biomarker for poor prognosis and a predictor of chemotherapy response in breast cancer. British journal of cancer, 2014, May-13, Volume: 110, Issue:10 Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Carcinoma; Combined Modality Therapy; Cyclophosphamide; DEAD-box RNA Helicases; Drug Resistance, Neoplasm; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Lymphocytes, Tumor-Infiltrating; Mastectomy; Menopause; Methotrexate; Mitotic Index; Neoplasm Invasiveness; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Prognosis; Proportional Hazards Models; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Treatment Outcome	2014
The prognostic impact of occult nodal metastasis in early breast carcinoma. Breast cancer research and treatment, 2009, Volume: 118, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Axilla; Bone Marrow; Breast Neoplasms; Carcinoma; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lymph Node Excision; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Neoplasm Staging; Neoplasms, Hormone-Dependent; Norway; Prognosis; Tamoxifen	2009
Oral metronomic cyclophosphamide with and without methotrexate as palliative treatment for patients with metastatic breast carcinoma. Anticancer research, 2012, Volume: 32, Issue:2 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cohort Studies; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Methotrexate; Middle Aged; Neoplasm Staging; Neoplasms, Hormone-Dependent; Palliative Care; Retrospective Studies	2012
Selective estrogen receptor modulators as inhibitors of repopulation of human breast cancer cell lines after chemotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research, 2003, Oct-01, Volume: 9, Issue:12 Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Cell Division; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; Fluorouracil; Humans; Methotrexate; Neoplasms, Hormone-Dependent; Piperidines; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Tamoxifen; Thiophenes; Tumor Cells, Cultured; Tumor Stem Cell Assay	2003
Clinical role of multidrug resistance protein 1 expression in chemotherapy resistance in early-stage breast cancer: the Austrian Breast and Colorectal Cancer Study Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Feb-20, Volume: 23, Issue:6 Topics: Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Austria; Biomarkers, Tumor; Breast Neoplasms; Chemotherapy, Adjuvant; Colorectal Neoplasms; Cyclophosphamide; Disease-Free Survival; Drug Resistance, Multiple; Female; Fluorouracil; Goserelin; Humans; Methotrexate; Multidrug Resistance-Associated Proteins; Neoplasms, Hormone-Dependent; Premenopause; Tamoxifen	2005
Worse survival for TP53 (p53)-mutated breast cancer patients receiving adjuvant CMF. Annals of oncology : official journal of the European Society for Medical Oncology, 2005, Volume: 16, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Cohort Studies; Female; Fluorouracil; Gene Expression Regulation, Neoplastic; Genes, p53; Genetic Markers; Humans; Methotrexate; Middle Aged; Mutation; Neoplasm Staging; Neoplasms, Hormone-Dependent; Polymerase Chain Reaction; Probability; Prognosis; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Survival Analysis; Tamoxifen	2005
Genomic alterations identified by array comparative genomic hybridization as prognostic markers in tamoxifen-treated estrogen receptor-positive breast cancer. BMC cancer, 2006, Apr-12, Volume: 6 Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Chromosomes, Artificial, Bacterial; Cluster Analysis; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; DNA, Neoplasm; Estrogen Receptor Modulators; Estrogens; Female; Fluorouracil; Humans; Life Tables; Mastectomy; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Nucleic Acid Hybridization; Oligonucleotide Array Sequence Analysis; Prognosis; Radiotherapy, Adjuvant; Receptors, Estrogen; Tamoxifen	2006
Comparison among different classification systems regarding the pathological response of preoperative chemotherapy in relation to the long-term outcome. Breast cancer research and treatment, 2009, Volume: 113, Issue:2 Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Docetaxel; Doxorubicin; Drug Monitoring; Estrogens; Female; Fluorouracil; Follow-Up Studies; Humans; Japan; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasms, Hormone-Dependent; Paclitaxel; Progesterone; Prognosis; Retrospective Studies; Taxoids; Trastuzumab; Treatment Outcome	2009
Sequential use of endocrine therapy and chemotherapy for metastatic breast cancer: effects on survival. Cancer treatment reports, 1980, Volume: 64, Issue:1 Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Fluorouracil; Humans; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Palliative Care; Prednisone; Time Factors; Vincristine	1980
Clinical response to chemotherapy and hormone therapy as first treatment after therapeutic ovariectomy in advanced breast cancer patients. Tumori, 1982, Apr-30, Volume: 68, Issue:2 Topics: Adult; Antineoplastic Agents; Breast Neoplasms; Castration; Cyclophosphamide; Dexamethasone; Doxorubicin; Female; Fluorouracil; Hormones; Humans; Methotrexate; Methyltestosterone; Middle Aged; Neoplasms, Hormone-Dependent; Progestins; Tamoxifen; Testosterone; Vincristine	1982
Evaluation of nonhormonal cytotoxic chemotherapy in the Nb rat (Pr-90) prostatic carcinoma. Cancer, 1980, Feb-15, Volume: 45, Issue:4 Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cardiomyopathies; Cyclophosphamide; Doxorubicin; Drug Evaluation, Preclinical; Lung Neoplasms; Male; Methotrexate; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Rats	1980
Evaluation of nonhormonal cytotoxic chemotherapy in the Nb rat prostate adenocarcinoma: autonomous tumor (18-Pr and 13-Pr). Cancer, 1980, Jul-15, Volume: 46, Issue:2 Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Evaluation, Preclinical; Fluorouracil; Male; Methotrexate; Neoplasm Transplantation; Neoplasms, Experimental; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Rats; Time Factors	1980
Assesssment of the effect of pretreatment with neoadjuvant therapy on primary breast cancer. British journal of cancer, 1996, Volume: 73, Issue:6 Topics: Adult; Aged; Androstenedione; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Goserelin; Humans; Immunohistochemistry; Methotrexate; Middle Aged; Mitomycin; Mitoxantrone; Neoplasms, Hormone-Dependent; Receptors, Estrogen	1996
Multidrug resistance in androgen-independent growing rat prostate carcinoma cells is mediated by P-glycoprotein. Urological research, 1997, Volume: 25, Issue:1 Topics: Androgens; Animals; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Fluorescent Dyes; Genes, MDR; Male; Methotrexate; Neoplasms, Hormone-Dependent; Paclitaxel; Prostatic Neoplasms; Rats; Rhodamine 123; Rhodamines; Tumor Cells, Cultured; Verapamil; Vinblastine	1997
Induction chemotherapy with versus without hormonal synchronisation in locally advanced breast cancer. Acta oncologica (Stockholm, Sweden), 1997, Volume: 36, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Division; Disease Progression; Estrogens; Female; Fluorouracil; G1 Phase; Humans; Methotrexate; Middle Aged; Neoplasms, Hormone-Dependent; Remission Induction; Tamoxifen	1997
Equivalence between ovarian suppression and chemotherapy in the adjuvant treatment of endocrine-responsive breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Apr-01, Volume: 20, Issue:7 Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Estrogen Receptor Modulators; Female; Fluorouracil; Humans; Meta-Analysis as Topic; Methotrexate; Middle Aged; Neoplasms, Hormone-Dependent; Premenopause; Randomized Controlled Trials as Topic; Tamoxifen; Treatment Outcome	2002
Altered subcellular localization of p53 in estrogen-dependent and estrogen-independent breast cancer cells. Cancer investigation, 2002, Volume: 20, Issue:4 Topics: Antineoplastic Agents, Hormonal; Apoptosis; Blotting, Northern; Blotting, Western; Breast Neoplasms; Cell Survival; DNA Primers; Doxorubicin; Drug Resistance, Neoplasm; Estradiol; Female; Humans; Immunoenzyme Techniques; Methotrexate; Neoplasms, Hormone-Dependent; Propidium; Reverse Transcriptase Polymerase Chain Reaction; RNA, Neoplasm; Subcellular Fractions; Tamoxifen; Transfection; Tumor Cells, Cultured; Tumor Suppressor Protein p53	2002
Use of a human lymphoid cell line to evaluate interactions between prednisolone and other chemotherapeutic agents. Cancer research, 1978, Volume: 38, Issue:11 Pt 2 Topics: Animals; Antineoplastic Agents; Cell Cycle; Cell Division; Cell Line; Clone Cells; Drug Interactions; Drug Therapy, Combination; Humans; Leukemia, Experimental; Leukemia, Lymphoid; Mercaptopurine; Methotrexate; Neoplasms, Hormone-Dependent; Prednisolone; Vincristine	1978
Combination hormonal, chemotherapy and radiotherapy in vitro: implications for therapy in vivo. International journal of radiation oncology, biology, physics, 1979, Volume: 5, Issue:9 Topics: Breast Neoplasms; Cell Line; Cell Survival; Cytarabine; Drug Therapy, Combination; Estradiol; Female; Humans; Methotrexate; Neoplasms, Hormone-Dependent; Tamoxifen	1979
[Prognostic and therapeutic significance of steroid receptors in invasive breast cancer]. Geburtshilfe und Frauenheilkunde, 1992, Volume: 52, Issue:10 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Lymph Node Excision; Mastectomy, Simple; Methotrexate; Neoplasms, Hormone-Dependent; Receptors, Estrogen; Receptors, Progesterone; Survival Analysis; Survival Rate; Tamoxifen	1992
Nuclear proteins of hamster hepatoma after administration of antitumour agents. Cytobios, 1992, Volume: 70, Issue:281 Topics: Animals; Antimetabolites, Antineoplastic; Cricetinae; Depression, Chemical; Electrophoresis, Gel, Two-Dimensional; Electrophoresis, Polyacrylamide Gel; Gene Expression Regulation, Neoplastic; Liver Neoplasms, Experimental; Male; Mesocricetus; Methotrexate; Molecular Weight; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Nuclear Proteins; Quinazolines; Testosterone	1992
[Adjuvant chemotherapy of breast cancer with the CMFV protocol]. Geburtshilfe und Frauenheilkunde, 1990, Volume: 50, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasms, Hormone-Dependent; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies; Survival Rate; Vincristine	1990
[Ablative hormone therapy and chemotherapy of metastatic breast cancer]. Zentralblatt fur Gynakologie, 1989, Volume: 111, Issue:23 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Liver Neoplasms; Lymph Node Excision; Mastectomy; Methotrexate; Middle Aged; Neoplasms, Hormone-Dependent; Ovariectomy	1989